calcium (2R,3S)-S-(4-aminophenyl)-N-(2-methylpropyl)-3-({[(2,2,5,5-2H4)oxolan-3-yloxy]carbonyl}amino)-4-phenyl-2-(phosphonatooxy)butane-1-sulfonamido

• ChemBase编号: 169441
• 分子式: C25H34CaN3O9PS
• 平均质量: 623.668921
• 单一同位素质量: 623.13792829
• SMILES: O(C(=O)N[C@H]([C@@H](CN(S(=O)(=O)c1ccc(cc1)N)CC(C)C)OP(=O)([O-])[O-])Cc1ccccc1)C1COCC1.[Ca+2]
• Canonical SMILES: CC(CN(S(=O)(=O)c1ccc(cc1)N)C[C@H]([C@H](Cc1ccccc1)NC(=O)OC1CCOC1)OP(=O)([O-])[O-])C.[Ca+2]
• InChI: InChI=1S/C25H36N3O9PS.Ca/c1-18(2)15-28(39(33,34)22-10-8-20(26)9-11-22)16-24(37-38(30,31)32)23(14-19-6-4-3-5-7-19)27-25(29)36-21-12-13-35-17-21;/h3-11,18,21,23-24H,12-17,26H2,1-2H3,(H,27,29)(H2,30,31,32);/q;+2/p-2/t21?,23-,24+;/m0./s1
• InChIKey: PMDQGYMGQKTCSX-UNNSCAPESA-L

名称和登记号

名称

• IUPAC标准名: calcium (2R,3S)-S-(4-aminophenyl)-N-(2-methylpropyl)-3-({[(2,2,5,5-^2H₄)oxolan-3-yloxy]carbonyl}amino)-4-phenyl-2-(phosphonatooxy)butane-1-sulfonamido
• IUPAC传统名: calcium (2R,3S)-S-(4-aminophenyl)-N-(2-methylpropyl)-3-({[(2,2,5,5-^2H₄)oxolan-3-yloxy]carbonyl}amino)-4-phenyl-2-(phosphonatooxy)butane-1-sulfonamido
• 别名: GW-433908G-d4; Lexiva-d4; Telzir-d4; Fosamprenavir-d4 Calcium Salt

登记号

• PubChem SID: 162263573
• PubChem CID: 45039302

理论计算性质

• Acid pKa: 1.222672
• 质子受体: 8
• 质子供体: 2
• LogD (pH = 5.5): -0.08588971
• LogD (pH = 7.4): -1.2002581
• Log P: 1.9187515
• 摩尔折射率: 142.711 cm^3
• 极化性: 56.949463 Å^3
• 极化表面积: 183.38 Å^2
• 可自由旋转的化学键: 13
• 里宾斯基五规则: false

分子性质

理化性质

• 溶解度: Methanol; Water
• 外观: White to Off-White Solid
• 熔点: >300°C (dec.)

安全信息

• 保存条件: Hygroscopic, -20°C Freezer, Under Inert Atmosphere

详细说明

Toronto Research Chemicals - F727252

HIV protease inhibitor; water soluble prodrug of amprenavir.

参考文献

• Falcoz, C., et al.: J. Clin. Pharmacol., 42, 887 92002), Chapman, T.M., et al.: Drugs, 64, 2101 (2004)